Natalizumab extended interval dosing (EID) is associated...

Revue Neurologique 2019 / 04 Vol. 175

Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the TOUCH® Prescribing Program

Zhovtis, Ryerson Lana, Foley, John, Chang, Ih, Kister, Ilya, Cutter, Gary, Metzger, Ryan, Goldberg, Judith D., Li, Xiaochun, Riddle, Evan, Smirnakis, Karen, Yu, Bei, Ren, Zheng, Hotermans, Christophe,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
175
Language:
english
Journal:
Revue Neurologique
DOI:
10.1016/j.neurol.2019.01.272
Date:
April, 2019
File:
PDF, 107 KB
english, 2019
Conversion to is in progress
Conversion to is failed